Predictive Factors for Second-Line Therapy in Metastatic Renal Cell Carcinoma: A Retrospective Analysis.

about

Biomarkers defining probability of receiving second-line targeted therapy in metastatic renal cell carcinoma.

P2860

Q54979573-EEB6B5F9-EF2D-41DD-8A3F-04C37C8B27FF

P2860

Predictive Factors for Second-Line Therapy in Metastatic Renal Cell Carcinoma: A Retrospective Analysis.

Item

http://www.wikidata.org/entity/Q53634559

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年学术文章

@wuu

2017年学术文章

@zh-cn

2017年学术文章

@zh-hans

2017年学术文章

@zh-my

2017年学术文章

@zh-sg

2017年學術文章

@yue

2017年學術文章

@zh

2017年學術文章

@zh-hant

name

Predictive Factors for Second- ...... oma: A Retrospective Analysis.

@en

Predictive Factors for Second- ...... oma: A Retrospective Analysis.

@nl

type

Item

label

Predictive Factors for Second- ...... oma: A Retrospective Analysis.

@en

Predictive Factors for Second- ...... oma: A Retrospective Analysis.

@nl

prefLabel

Predictive Factors for Second- ...... oma: A Retrospective Analysis.

@en

Predictive Factors for Second- ...... oma: A Retrospective Analysis.

@nl

P1476

Predictive Factors for Second- ...... oma: A Retrospective Analysis.

@en

P2093

Hendrik Eggers

http://www.w3.org/2001/XMLSchema#string

Mareike Hornig

http://www.w3.org/2001/XMLSchema#string

Philipp Ivanyi

http://www.w3.org/2001/XMLSchema#string

Viktor Grünwald

http://www.w3.org/2001/XMLSchema#string

P2860

Pazopanib versus sunitinib in metastatic renal-cell carcinoma.

Post-treatment neutrophil-to-lymphocyte ratio in predicting prognosis in patients with metastatic clear cell renal cell carcinoma receiving sunitinib as first line therapy.

The association of clinical outcome to first-line VEGF-targeted therapy with clinical outcome to second-line VEGF-targeted therapy in metastatic renal cell carcinoma patients

External validation and comparison with other models of the International Metastatic Renal-Cell Carcinoma Database Consortium prognostic model: a population-based study

The International Metastatic Renal Cell Carcinoma Database Consortium model as a prognostic tool in patients with metastatic renal cell carcinoma previously treated with first-line targeted therapy: a population-based study.

Depth of remission is a prognostic factor for survival in patients with metastatic renal cell carcinoma

Prognostic model for survival in patients with metastatic renal cell carcinoma: results from the international kidney cancer working group.

Prognostic factors for survival in patients with metastatic renal cell carcinoma treated with targeted therapies.

Prognostic Biomarkers for Response to Vascular Endothelial Growth Factor-Targeted Therapy for Renal Cell Carcinoma.

Precision Oncology: Identifying Predictive Biomarkers for the Treatment of Metastatic Renal Cell Carcinoma

P304

8-15

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.15586/JKCVHL.2017.59

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2017-03-21T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

28405544

http://www.w3.org/2001/XMLSchema#string

P921

cell line

P932

5364333

http://www.w3.org/2001/XMLSchema#string

Predictive Factors for Second-Line Therapy in Metastatic Renal Cell Carcinoma: A Retrospective Analysis.

about

P2860

P2860

Predictive Factors for Second-Line Therapy in Metastatic Renal Cell Carcinoma: A Retrospective Analysis.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P577

P698

P921

P932

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P577

P698

P921

P932